At a glance
ClinicalIndex Comparison RecordN/ACompleted· 66 enrolled
Drug / intervention
moderate intensity continuous trainingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and Glucagon Like Peptide Hormone in Irritable Bowel Syndrome
In Brief
A clinical study evaluating moderate intensity continuous training for Irritable Bowel Syndrome and 2 related conditions. Completed, enrolled 66 participants across 2 sites.
Detailed Summary
investigating the response of gut bacteria via measuring short chain fatty acids and Glucagon like peptide hormone to two different modes of exercises in pre-diabetic, obese patients with irritable bowel syndrome. It will be hypothesized that there will be no significant difference between the moderate continuous versus high interval intensity training on gut dysbiosis and glucagon like peptide hormone in irritable bowel syndrome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIrritable Bowel Syndrome, Obesity, Dysbiosis
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartMay 2024
First PostedMay 2024
Primary CompletionMay 2025
Study CompletionMay 2025
TodayJul 2026
First PostedMay 10, 2024
Enrollment StartMay 1, 2024
Primary CompletionMay 15, 2025
Study CompletionMay 17, 2025
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 2.1 years ago
Interventions
moderate intensity continuous trainingother
exercise and diet